The management of epilepsy has witnessed significant advancements over the past years. This article aims to provide an update on these developments, focusing on novel therapeutic strategies, technology-assisted monitoring, and improved diagnostic techniques.
Recent years have seen the introduction of new antiepileptic drugs (AEDs) with unique mechanisms of action, such as perampanel, a selective non-competitive AMPA receptor antagonist, and brivaracetam, a high-affinity synaptic vesicle protein 2A ligand. These drugs offer improved seizure control and better tolerability. Additionally, there has been a resurgence in interest in dietary therapies, particularly the ketogenic diet, for drug-resistant epilepsy.
Wearable technology and smartphone applications are emerging as useful tools in epilepsy management. These devices can detect seizures, track seizure frequency, and even predict seizures in some cases. The data collected can aid in treatment personalization and enhance patient autonomy. Furthermore, telemedicine has proven to be an effective tool for remote patient monitoring and follow-up, especially during the COVID-19 pandemic.
Advancements in neuroimaging, such as high-resolution MRI and positron emission tomography (PET), have improved the localization of epileptogenic foci, aiding in surgical planning. Genetic testing has also become more accessible, enabling the identification of specific epilepsy syndromes and guiding targeted therapy.
In conclusion, the landscape of epilepsy management is evolving rapidly, with advancements in therapeutic strategies, technology-assisted monitoring, and diagnostic techniques. These developments hold the promise of improving seizure control, reducing treatment side effects, and enhancing the quality of life for individuals with epilepsy. It is crucial for healthcare professionals to keep abreast of these advancements to provide optimal care for their patients.
1.
Promising OS at 5 Years With Chemo-Free Combo in Urothelial Cancer
2.
Black Canadians Face Multiple Barriers to Blood Donation
3.
Stop Calling It Cancer; The Alcohol Paradox; Rural Patients Lose Ground in Screening
4.
Experts say oncology, primary care coordination necessary for best cancer patient outcomes
5.
Neural networks and label-free microscopy enable accurate detection of pancreatic tumors
1.
Machine Learning in Hematology: Boosting Diagnostic Precision and Speed in Medical Practice
2.
Advancing Cancer Care: Insights into Oncology Trials, Immunotherapy, and CAR-T Innovations
3.
Clinical Frameworks in Hematology for Better Care
4.
Empowering Lung Cancer Diagnosis Through the Synergy of Advanced Technologies and Artificial Intelligence
5.
The Benefits of Understanding Haptoglobin High: What You Need to Know
1.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
2.
International Cancer Conference
3.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part II
3.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
4.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
5.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation